Veterinary Medicines

KESIUM 40 MG / 10 MG CHEWABLE TABLETS FOR CATS AND DOGS

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate
Download as PDF

Product identification

Medicine name:
KESIUM 40 MG / 10 MG CHEWABLE TABLETS FOR CATS AND DOGS
Kesium 40 mg / 10 mg rágótabletta kutyák és macskák számára
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    45.90
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    11.90
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:
  • Box of 1 blister (PA-AL-PVC – aluminium heat sealed) of 10 tablets
  • Box of 24 blisters (PA-AL-PVC – aluminium heat sealed) of 10 tablets
  • Box of 10 blisters (PA-AL-PVC – aluminium heat sealed) of 10 tablets
  • Box of 8 blisters (PA-AL-PVC – aluminium heat sealed) of 10 tablets
  • Box of 6 blisters (PA-AL-PVC – aluminium heat sealed) of 10 tablets
  • Box of 4 blisters (PA-AL-PVC – aluminium heat sealed) of 10 tablets
  • Box of 2 blisters (PA-AL-PVC – aluminium heat sealed) of 10 tablets
  • Box of 48 blisters (PA-AL-PVC – aluminium heat sealed) of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 2992/X/23 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0225/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)